Meeting Coverage
IDWeek
A Joint Meeting of IDSA, SHEA, HIVMA, PIDS, and SIDP
Latest IDWeek Meeting Coverage
Trials meet all primary aims, poising them to advance toward clinical use
Use of cefepime meanwhile resulted in more neurological dysfunction
One dose proved noninferior to triple-dose regimen in randomized trial
Antiviral protected older at-risk patients, but appeared to increase risk in teens
And second dose after 1 year appeared to add no extra protection
Findings may encourage increased pediatric vaccine uptake, researcher says
Association strongest with exclusive breastfeeding
Delabeling strategy carries little risk, needs minimal testing, and no specialist consult
While not quite as sensitive as saliva PCR testing, dried blood spot testing has promise
High mortality in outbreak linked to anesthesia in Mexico
Fostamatinib reduced time on supplemental oxygen, improved clinical status
Plus: Detecting viruses in wastewater and the maternal RSV vaccine for protecting infants
Those in long-term care facilities are particularly at risk, researcher says
Trials show upwards of 85% protection against more severe cases of respiratory syncytial virus
Latest Infectious Disease Meeting Coverage
-
IDWeek: A Joint Meeting of IDSA, SHEA, HIVMA, PIDS, and SIDP
October 2024
-
CROI: Conference on Retroviruses and Opportunistic Infections
March 2024
-
ASTMH: American Society of Tropical Medicine & Hygiene
October 2022
-
IDWeek Podcast: Podcast from the Joint Meeting of IDSA, SHEA, HIVMA, and PIDS
October 2020